Bill > HR7647

Introduced Session

To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage. This bill delays until the first calendar year that is 12 months after the end of the COVID-19 (i.e., coronavirus disease 2019) public health emergency the application of the Centers for Medicare & Medicaid Services (CMS) rule dated May 14, 2020. That rule allows private health insurance plans to decide whether support provided by a prescription drug manufacturer to cover a patient's costs for a drug counts toward the patient's annual out-of-pocket limit. The bill requires enforcement of the previous rule, which allows plans to exclude drug manufacturer support from a patient's annual out-of-pocket limit only if a generic version of the drug is available.

AI Summary

Committee Categories

Donald McEachin (D)*,  Pete Aguilar (D),  Nanette Barragán (D),  Lisa Blunt Rochester (D),  G. Butterfield (D),  André Carson (D),  Yvette Clarke (D),  Lou Correa (D),  Angie Craig (D),  Rodney Davis (R),  Brian Fitzpatrick (R),  Ruben Gallego (D),  Vicente Gonzalez (D),  Alcee Hastings (D),  Kendra Horn (D),  Bill Keating (D),  Robin Kelly (D),  Ann Kuster (D),  Barbara Lee (D),  Ted Lieu (D),  Lucy McBath (D),  Grace Napolitano (D),  Tom O'Halleran (D),  Collin Peterson (D),  Harley Rouda (D),  Bobby Rush (D),  Michael San Nicolas (D),  Brad Schneider (D),  Kurt Schrader (D),  Mikie Sherrill (D),  Darren Soto (D),  Abigail Spanberger (D),  Tom Suozzi (D),  Bennie Thompson (D),  David Trone (D),  Jeff Van Drew (R),  Marc Veasey (D),  Bonnie Watson Coleman (D), 

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Labor, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 07/16/2020)

Official Document